{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:40:22Z","timestamp":1772160022690,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/bjd.14642","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T08:14:47Z","timestamp":1460276087000},"page":"1382-1386","source":"Crossref","is-referenced-by-count":106,"title":["Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases"],"prefix":"10.1093","volume":"175","author":[{"given":"L.","family":"Borradori","sequence":"first","affiliation":[{"name":"Moores Cancer Center; University of California San Diego; 3855 Health Sciences Drive La Jolla CA 92093 U.S.A."},{"name":"Department of Dermatology; University Hospital; University of Bern; Freiburgstrasse 3010 Bern Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Moores Cancer Center; University of California San Diego; 3855 Health Sciences Drive La Jolla CA 92093 U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Shayesteh","sequence":"additional","affiliation":[{"name":"Moores Cancer Center; University of California San Diego; 3855 Health Sciences Drive La Jolla CA 92093 U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Daniels","sequence":"additional","affiliation":[{"name":"Moores Cancer Center; University of California San Diego; 3855 Health Sciences Drive La Jolla CA 92093 U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"10.1111\/bjd.14642-BIB0001|bjd14642-cit-0001","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14642-BIB0002|bjd14642-cit-0002","doi-asserted-by":"publisher","DOI":"10.1097\/COC0000000000000088","article-title":"Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): the Roswell Park experience and a review of the literature","author":"Jarkowski","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1111\/bjd.14642-BIB0003|bjd14642-cit-0003","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.14642-BIB0004|bjd14642-cit-0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1111\/bjd.14642-BIB0005|bjd14642-cit-0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","article-title":"The next immune-checkpoint inhibitors: PD-1\/PD-L1 Blockade in Melanoma","volume":"37","author":"Mahoney","year":"2015","journal-title":"Clin Ther"},{"key":"10.1111\/bjd.14642-BIB0006|bjd14642-cit-0006","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.18632\/oncotarget.6429","article-title":"Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma","volume":"7","author":"Darb-Esfahani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1111\/bjd.14642-BIB0007|bjd14642-cit-0007","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1111\/bjd.14642-BIB0008|bjd14642-cit-0008","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.14642-BIB0009|bjd14642-cit-0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2016","journal-title":"Cancer"},{"key":"10.1111\/bjd.14642-BIB0010|bjd14642-cit-0010","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1084\/jem.20071190","article-title":"Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells","volume":"205","author":"Clark","year":"2008","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.14642-BIB0011|bjd14642-cit-0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamadermatol.2015.2705","article-title":"A case report of unresectable cutaneous squamous cell carcinoma responsive to pembrolizumab, a programmed cell death protein 1 inhibitor","volume":"152","author":"Chang","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.14642-BIB0012|bjd14642-cit-0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.14642-BIB0013|bjd14642-cit-0013","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/0008-5472.CAN-10-2217","article-title":"B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.14642-BIB0014|bjd14642-cit-0014","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1111\/bjd.14642-BIB0015|bjd14642-cit-0015","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14642","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14642\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:20:28Z","timestamp":1676366428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/6\/1382\/6698455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14642","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726278818.793546348","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,17]]}}}